FDA Approved: EMGALITY — Original Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved EMGALITY (galcanezumab) under the original application filed by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Emgality (galcanezumab)

Snippet

ORIG AP for EMGALITY (GALCANEZUMAB-GNLM)